Alibaba Health Information Technology Limited (ALBBY)

OTCMKTS · Delayed Price · Currency is USD
11.15
0.00 (0.00%)
At close: May 1, 2026
Market Cap9.23B -1.2%
Revenue (ttm)4.64B +16.5%
Net Income271.11M +60.0%
EPS0.02 +51.8%
Shares Outn/a
PE Ratio34.04
Forward PE23.61
Dividendn/a
Ex-Dividend Daten/a
Volume141
Average Volume805
Open11.15
Previous Closen/a
Day's Range11.15 - 11.15
52-Week Range8.95 - 19.45
Beta1.59
RSI41.27
Earnings DateMay 14, 2026

About ALBBY

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical c... [Read more]

Sector Healthcare
Founded 1998
Employees 1,357
Stock Exchange OTCMKTS
Ticker Symbol ALBBY

Financial Performance

In fiscal year 2025, ALBBY's revenue was 30.60 billion, an increase of 13.22% compared to the previous year's 27.03 billion. Earnings were 1.43 billion, an increase of 62.14%.

Financial numbers in CNY Financial Statements

News

Apps in Beijing's crosshairs as crackdown heats up

U.S.-traded shares of several China-based tech-related firms, including Alibaba Holding, Tencent Music Entertainment Group and iQiyi, slid on Thursday in the wake of Beijing's findings that 43 apps il...

5 years ago - Reuters

China's digital health care start-ups get a boost from the coronavirus, Beijing and investors

The coronavirus pandemic is proving to be the accelerator that China's health care technology start-ups needed.

6 years ago - CNBC

Alibaba Health raises $1.3 billion in Hong Kong's biggest secondary share sale in 5 years

Chinese healthcare services firm Alibaba Health Information Technology has raised nearly $1.3 billion in Hong Kong's largest follow-on share sale in five years, according a statement from the company ...

6 years ago - Reuters